Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.